|
1
|
Hasskarl J, Ihorst G, De Pasquale D, et
al: Association of multiple myeloma with different neoplasms:
systematic analysis in consecutive patients with myeloma. Leuk
Lymphoma. 52:247–259. 2011.
|
|
2
|
Law IP and Blom J: Second malignancies in
patients with multiple myeloma. Oncology. 34:20–24. 1977.
|
|
3
|
Tzeng HE, Lin CL, Tsai CH, et al: Time
trend of multiple myeloma and associated secondary primary
malignancies in Asian patients: a Taiwan population-based study.
PLoS One. 8:e680412013.
|
|
4
|
Fujita H, Matsuzaki M, Murata T, et al:
Three M-components (IgG kappa, IgA kappa, IgM kappa) in a patient
with non-Hodgkin’s lymphoma. Rinsho Ketsueki. 33:384–390. 1992.(In
Japanese).
|
|
5
|
Milnik A, Roggenbuck D, Conrad K and
Bartels C: Acute inflammatory neuropathy with monoclonal anti-GM2
IgM antibodies, IgM-κ paraprotein and additional autoimmune
processes in association with a diffuse large B-cell non-Hodgkin’s
lymphoma. BMJ Case Rep. 2013:2013.
|
|
6
|
Travis LB, Rabkin CS, Brown LM, et al:
Cancer survivorship - genetic susceptibility and second primary
cancers: research strategies and recommendations. J Natl Cancer
Inst. 98:15–25. 2006.
|
|
7
|
Shimizu Y, Schull WJ and Kato H: Cancer
risk among atomic bomb survivors. The RERF Life Span Study
Radiation Effects Research Foundation. JAMA. 264:601–604. 1990.
|
|
8
|
Preston DL, Kusumi S, Tomonaga M, et al:
Cancer incidence in atomic bomb survivors. Part III Leukemia,
lymphoma and multiple myeloma, 1950–1987. Radiat Res. 137(2 Suppl):
S68–S97. 1994.
|
|
9
|
Landgren O: A role for ionizing radiation
in myelomagenesis? Blood. 113:1616–1617. 2009.
|
|
10
|
Iwanaga M, Hsu WL, Soda M, et al: Risk of
myelodysplastic syndromes in people exposed to ionizing radiation:
a retrospective cohort study of Nagasaki atomic bomb survivors. J
Clin Oncol. 29:428–434. 2011.
|
|
11
|
Gold LS, Stewart PA, Milliken K, et al:
The relationship between multiple myeloma and occupational exposure
to six chlorinated solvents. Occup Environ Med. 68:391–399.
2011.
|
|
12
|
Sonoda T, Ishida T, Mori M, et al: A
case-control study of multiple myeloma in Japan: association with
occupational factors. Asian Pac J Cancer Prev. 6:33–36. 2005.
|
|
13
|
Mailankody S, Pfeiffer RM, Kristinsson SY,
et al: Risk of acute myeloid leukemia and myelodysplastic syndromes
after multiple myeloma and its precursor disease (MGUS). Blood.
118:4086–4092. 2011.
|
|
14
|
Nagamura F, Goto S, Iseki T, et al:
Molecular evidence for a single clonal origin in a patient with
multiple myeloma and non-Hodgkin’s lymphoma. Rinsho Ketsueki.
36:1182–1187. 1995.
|
|
15
|
Chim CS, Ma SK and Leung CY: Malignant
lymphoma masquerading as multiple myeloma. Leuk Lymphoma.
28:607–611. 1998.
|
|
16
|
Anderson KC, Alsina M, Bensinger W, et al;
National Comprehensive Cancer Network. NCCN clinical practice
guidelines in oncology: multiple myeloma. J Natl Compr Canc Netw.
7:908–942. 2009.
|
